Lifecore Biomedical, Inc. LFCR Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings?
- Lifecore Biomedical, Inc. (LFCR) reported fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings of -$3.16M in Q1 2026.
- What does fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings mean?
- This metric tracks the change in earnings resulting from the revaluation of liabilities measured using Level 3 inputs, which are based on unobservable market data. It reflects the volatility associated with complex financial instruments or derivative liabilities that lack active market pricing. Monitoring this helps investors understand the impact of non-cash valuation adjustments on the company's reported net income.